Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Enzyme Discovered May Lead to Better TB Test

By LabMedica International staff writers
Posted on 31 Jan 2013
An enzyme has been identified that will trigger the rapid breakdown of several Mycobacteria, which could lead to better tests for the deadly tuberculosis infection.

The current bacterial culture test for tuberculosis infections is highly accurate but time-consuming, taking up to several weeks, while the diagnostic process called nucleic acid-based amplification (NAA) faces difficulty in breaking open, or lysing bacteria. More...


Scientists at University of Pittsburgh Graduate School of Public Health (PA, USA) show that exposure to an enzyme called esterase from Mycobacterium smegmatis hydrolyzes the ester linkage of trehalose dimycolate in vitro, which triggers the rapid and efficient lysis of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium marinum.

A rapid and efficient lysis of trehalose dimycolate hydrolase (TDMH) exposed M. tuberculosis, and a subsequent release of nucleic acids (NA) offered a unique opportunity to use this enzyme for achieving more sensitive detection in a nucleic acid amplification assay for the diagnosis of tuberculosis (TB). The nucleic content in the supernatant of TDMH-exposed bacilli started to increase within 30 minutes of exposure, and it peaked at around 60 minutes.

Treatment of samples with TDMH prior to the amplification reaction facilitated the NA detection in 37 samples, a highly significant improvement in the numbers of positive detection. The investigators also demonstrated that this quick lysis of M. tuberculosis improved its detection at lower density.

Anil Ojha, PhD, an assistant professor and senior author of the study said, "Tuberculosis is a huge public health burden. Clearly, controlling the infection is heavily dependent upon an effective diagnosis. Discovery of enzyme-based mycobacteria lysis has the potential to increase the sensitivity of NAA." The study was published on January 4, 2013, in the Journal of Biological Chemistry.

Related Links:
University of Pittsburgh


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.